Navigation Links
Microarray Target Purification Kit and,,,the Microarray Target Synthesis Kit (T7)

As the human genome sequence project is completed, the vast amount of genomic information calls for methods that allow gene expression analysis on a genomic scale and speed up detection of significant sequence variations. The most suitable tools available for gene expression analysis are DNA hybridization arrays that allow researchers to examine differences in expression of hundreds or thousands of genes in parallel. That is why DNA arrays, on a variety of platforms such as macroarrays, microarrays or high-density oligonucleotide arrays make their way into different areas of functional genomics research. Arrays provide immobilized gene-specific sequences (probes) on different solid supports (e.g., nylon membranes, glass slides, or silicon/ceramic chips) and are hybridized with labeled targets that are copies of nucleic acids derived from various biological sources.



This requires reliable and efficient tools for preparation and labeling of targets: RNA needs to be extracted from small amounts of precious sample materials, and labeled either directly during cDNA preparation or via a linear amplification (100 to 1000 fold) with T7 polymerase producing labeled cRNA, or via polymerase chain reaction (PCR)-based amplification methods. This step must be highly reproducible and efficient to avoid differences in hybridization caused by biased amplification of target material.

Therefore, Roche Applied Science has developed a range of DNA microarray analysis products for expression profiling, suitable especially for very small amounts of starting material or when highest sensitivity is required. Each product is designed and tested in combination with the others to cover the critical
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. New Microarray Labeling Kit for Preparing cDNA Probes
2. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
3. An Optimal DNA Microarray Substrate for the Identification of Fetal and Somatic Liver Stem Cells of the Rat
4. Amplification of Mouse cDNAs for Microarrays Using the Eppendorf MasterTaq Kit
5. Use of Transcriptor Reverse Transcriptase in Microarray Analysis
6. Increased Sensitivity in Microarray Analysis
7. Analysis of Microarray Data
8. Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform
9. Is RNA Amplification Necessary for Microarrays?
10. Perform Microarray Analysis with Limited Bacterial RNA
11. Isolate High Quality Total RNA from LCM Samples Suitable for Microarray and qRT-PCR Analysis
Post Your Comments:
(Date:7/24/2008)...Md., July 24 /- United,Ther...day that it will,release its 2008 second quarter f...sday, July 31, 2008., United Therapeutics will ho..., 2008, at 9:00 a.m. Eastern Time. The teleconfere...international callers dialing,1-706-679-8129. A re...
(Date:7/24/2008)... and JERSEY CITY, New Jersey, July 24,/PRNewswire-... ), a leader in,the development of microRNA-based ... it has successfully completed the acquisition of ...privately-held company owning a,CLIA-certified lab...te,purchase price of $2,900,000, consisting of $1,...
(Date:7/23/2008)...TTE, Ind. - Researchers have overcome a major obst...bon nanotubes, a technology that could make it pos...ications including flexible displays and an electr...rack formation. , The so-called "nanonet" techno...randomly overlapping in a fishnet-like structure -...
(Date:7/23/2008)...y 23 /- Troutman Sanders Public Affai...ernmental affairs firm on,Capitol Hill and across ...ers Strategies. The D.C. office has a proven track...ns, trade, energy, environment and,transportation ...he firm,s substantial growth since its,founding in...
Breaking Biology Technology:Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 2Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 3Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 4Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. 5'Nanonet' circuits closer to making flexible electronics reality 2'Nanonet' circuits closer to making flexible electronics reality 3'Nanonet' circuits closer to making flexible electronics reality 4Leading Lobbying Firm Celebrates Growth and New Name: Troutman Sanders Strategies 2
..., Ambion,s newest line of pla..., p Silencer 4.1-CMV, , fe...nscription , of both an siRNA t... The CMV promoter is used to drive si...romoter is active in a broad range of cell types a...
...Efficient Cellular Fractionation for RNA , ... Ambion,s Protein and RNA Isolation...and simple procedure to isolate both , ... experimental , sample. Culture... frozen, or treated with RNA stabiliz...
...,, The siRNA design , algorithm d...partnered to , develop a genome wide siRNA ... the design rules first described by Tuschl and...As featuring the Tuschl design rules (target sites...oth the sense and antisense siRNA strands, , ...
..., Both recombinant human , ...sed in , vitro to cleave long d... effective mediators of gene silencing ...clease that contains RNase III domains and is the ...ge of long dsRNAs to siRNA in the , ...
Other Biology Technology:Drive Long-Term Silencing with CMV Vectors 2Drive Long-Term Silencing with CMV Vectors 3Efficient Cellular Fractionation for RNA , and Protein Isolation 2Efficient Cellular Fractionation for RNA , and Protein Isolation 3Efficient Cellular Fractionation for RNA , and Protein Isolation 4Efficient Cellular Fractionation for RNA , and Protein Isolation 5Efficient Cellular Fractionation for RNA , and Protein Isolation 6Efficient Cellular Fractionation for RNA , and Protein Isolation 7Designing a Better siRNA 2Designing a Better siRNA 3Designing a Better siRNA 4Designing a Better siRNA 5Dicer vs. RNase III for Preparation of siRNA Cocktails 2Dicer vs. RNase III for Preparation of siRNA Cocktails 3
(Date:7/23/2008)...g together internationally renowned scientists fro... Japan, Australia and India to address ancient mi..."We are bringing together the world,s best scienti...anizer J. William Schopf, founder and director of ...sics, Center for the Study of Evolution and the Or...
(Date:7/23/2008)...study of free-living and parasitic species in thre... Baja California, a team of researchers from the U... States Geological Survey, and Princeton Universit...bitats exceeds that of top predators, in some case...ave significant biomedical and ecological implicat...
(Date:7/23/2008)... fonder, but endurance exercise seems to make it y...on University School of Medicine in St. Louis, old...about a year ended up with metabolically much youn...e metabolic measure, women benefited more than men...teriorates as people get older, and that,s largely...
(Date:7/23/2008)... (UK) are working on new ways of storing CO 2 emi...obal warming. , The University has launched the ...y the newly-created position of Professor of Carbo...chers aim to find efficient and reliable ways of g... and storing it in former oil and gas fields or aq...
Breaking Biology News(10 mins):UCLA 'world summit' to explore ancient life on Earth, and beyond 2Study shows parasites outweigh predators 2Study shows parasites outweigh predators 3Exercise could be the heart's fountain of youth 2Exercise could be the heart's fountain of youth 3Durham scientists to tackle CO2 storage in global warming challenge 2Aeras Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in So 1719 1Aeras Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in So 1719 2Aeras Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in So 1719 3Aeras Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in So 1719 4Aeras Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in So 1719 5Aeras Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in So 1719 6VaxGen Restructures Following Termination of Proposed Merger 16329 1VaxGen Restructures Following Termination of Proposed Merger 16329 2SAIC Awarded 2416 Million Contract by General Services Administration 16325 1SAIC Awarded 2416 Million Contract by General Services Administration 16325 2Kansas state flower receives scientific attention 2824 1Kansas state flower receives scientific attention 2824 2
...ect has heated up over the past year as more and m...logical responses to placebos. A new study takes p...inical trial, showing a discernible placebo effect...British Medical Journal. , While researchers usua...fectiveness of a new treatment, this trial pitted ...
...odies (mAbs) increases their toxicity to cancer ce... cancer therapies, according to research conducted...4 print issue of the Proceedings of the National A...s have important advantages over chemotherapy and ... their specificity in targeting tumor cells and lo...
...tins do not appear to reduce the incidence of canc...of previous studies in the January 4 issue of JAMA...ce the risk of developing cancer, the authors prov...e. "Statins have been studied in numerous large-s...ials for primary and secondary prevention of coron...
...in "watchdog" on high alert to stop hereditary can...p it on a leash of just the right length. , In a c...g Purdue University,s Susan M. Mendrysa has found ...has the ability to halt the progression of intesti... When the activity of this protein, known only by ...
Other Biology News:All placebos not created alike 2Data published in PNAS show antibodies can be made 10 times more toxic to cancer cells 2Statins have neutral effect on risk of cancer 2Loosen leash on cancer protein 'watchdog,' researchers say 2Loosen leash on cancer protein 'watchdog,' researchers say 3Loosen leash on cancer protein 'watchdog,' researchers say 4
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C
CD69/CD3 50 tests
Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749
Rabbit polyclonal to pCrosstide (HRP) ( Abpromise for all tested applications).
Biology Products: